Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon purchased 30 shares of the stock in a transaction on Wednesday, January 22nd. The shares were purchased at an average price of GBX 1,362 ($17.00) per share, for a total transaction of £408.60 ($510.05).
Johnson Matthey Stock Performance
LON JMAT opened at GBX 1,376 ($17.18) on Friday. The company has a 50-day simple moving average of GBX 1,378.95 and a two-hundred day simple moving average of GBX 1,508.96. Johnson Matthey PLC has a 12-month low of GBX 1,295.54 ($16.17) and a 12-month high of GBX 1,917.07 ($23.93). The firm has a market cap of £2.40 billion, a price-to-earnings ratio of 2,372.41, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 63.15.
Johnson Matthey (LON:JMAT – Get Free Report) last released its earnings results on Wednesday, November 27th. The company reported GBX 57.40 ($0.72) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.39% and a net margin of 0.84%. On average, equities analysts forecast that Johnson Matthey PLC will post 173.4112903 EPS for the current year.
Johnson Matthey Cuts Dividend
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on JMAT shares. Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.47) price objective on shares of Johnson Matthey in a research report on Tuesday, December 17th. Berenberg Bank reduced their price target on shares of Johnson Matthey from GBX 1,650 ($20.60) to GBX 1,500 ($18.72) and set a “hold” rating on the stock in a research report on Thursday, November 28th.
Read Our Latest Stock Report on Johnson Matthey
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Read More
- Five stocks we like better than Johnson Matthey
- What is the MACD Indicator and How to Use it in Your Trading
- Bloom Energy: Powering the Future With Decentralized Energy
- The 3 Best Blue-Chip Stocks to Buy Now
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.